智通财经APP讯，昭衍新药(06127)发布公告，该公司于近日收到姚大林博士(姚博士)的辞职函。姚博士因工作安排辞去公司执行董事及公司副总经理职务。姚博士已确认，彼与董事会并无意见分歧，亦无其他因辞任而需知会股东的事宜。姚博士辞去上述职务后，将继续在公司其他子公司任职。
董事会议决提名罗樨女士(罗女士)为公司执行董事(执行董事)。建议委任罗女士须待股东于公司2025年第一次临时股东大会上以普通决议案形式批准后，方告作实。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.